Important

Research Use Notice

All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.

Product Documentation

Details, specifications, and documents

Description

CJC-1295 NO DAC + Ipamorelin

Buy CJC-1295 + Ipamorelin blend with NO DAC CJC-1295: 5 mg of each peptide and 10 mg total labeled material. It is supplied as lyophilized powder in one boxed 3 mL vial for laboratory research.

  • CJC-1295 NO DAC: 5 mg
  • Ipamorelin: 5 mg
  • Total blend: 10 mg per vial

Blend or separate compounds?

A premixed vial fixes the labeled component proportions. If an experiment requires independent amounts, separate CJC-1295 NO DAC and Ipamorelin listings are available. Compare the complete formulations before treating a blend as equivalent to separately prepared materials.

The CJC component is the same standard 29-amino-acid modified GRF(1-29) used in our standalone NO DAC product, reference CAS 446036-97-1. It has no DAC attachment. Replacing it with a DAC-bearing form, or replacing Ipamorelin with GHRP-2, creates a different blend.

What the component studies show

In Raun and colleagues’ original Ipamorelin study, primary rat pituitary cells released growth hormone. Antagonist experiments distinguished a GHRP-like receptor response from the GHRH pathway. The study characterized Ipamorelin and included animal experiments; it did not test this commercial mixture.

The CJC-1295 development study examined albumin-reactive modified GRF constructs. Those persistence results are not evidence for a NO DAC blend. Studying both pathways together requires controls that separate each component’s response from the response of the mixture; synergy is not established by combining two labels.

Read the blend’s analytical records

These are labeled amounts. In the available analytical records, check which components were identified and which were quantified. One overall chromatographic purity result does not necessarily report a separate purity or amount for each peptide.

Keep component identity, formulation ratio and the report’s test methods together when matching the material to a protocol. The 3 mL capacity describes the container, not a prescribed preparation volume. Handling and stability information should apply to the complete mixture rather than being inferred from one ingredient alone.

Additional information

CAS No.

CJC-1295 NO DAC: 446036-97-1, Ipamorelin: 170851-70-4

Applications

Growth hormone research, muscle regeneration studies, metabolic function research

Purity

≥99%

Synthesis

Solid-phase synthesis

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for up to 24 months at -20°C.

Appearance

White lyophilized powder

Shipping Conditions

Shipped at ambient temperature; once received, store at -20°C

Regulatory/Compliance

Manufactured in a facility that adheres to cGMP guidelines

Safety Information

Refer to provided MSDS

COA & Documents

Independent lot testing

CJC-1295 NO DAC + Ipamorelin (10mg Blend) Certificate of Analysis

This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.

Lot number
84704
Report number
IF-824-QSA-TR006-2026-127-22
Date tested
March 2, 2026
Reported purity
99.8%
Labeled content
10 mg
DOWNLOADABLE RESOURCES

Product documents

Product information and laboratory resources. For lot-specific results, use the COA above.

PDF

Product & packaging information

Labeled amount, physical form and packaging for CJC-1295 NO DAC + Ipamorelin (10mg Blend).

Revision 0.4 · 2026-10-05Download PDF
PDF

Laboratory handling guide

General guidance for applicable lyophilized research materials. Not a product-specific SDS.

Revision 1.0 · 2026-09-22Download PDF
General guides & resources

Need Assistance?

Questions about product documentation?

Contact our support team for help with product records, lot information, orders or certificate verification.

Contact Support